The Latest
-
Cara Therapeutics'(NASDAQ:CARA) Share Price Is Down 31% Over The Past Year.
-
AstraZeneca ties up with IQVIA to speed up studies of COVID-19 vaccine candidate
-
J.P. Morgan: 3 Strong Value Stocks to Buy Now
-
The Best-Performing Fidelity Funds for Retirement